Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001863396 | SCV002117177 | pathogenic | Hereditary spastic paraplegia 39 | 2020-10-30 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser372Leufs*22) in the PNPLA6 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PNPLA6 are known to be pathogenic (PMID: 24355708). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals with PNPLA6-related conditions. This variant is not present in population databases (ExAC no frequency). |